Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation

Pigment Cell Melanoma Res. 2008 Aug;21(4):492-3. doi: 10.1111/j.1755-148X.2008.00475.x. Epub 2008 May 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Amino Acid Substitution / genetics
  • Anus Neoplasms / drug therapy*
  • Anus Neoplasms / genetics
  • Anus Neoplasms / pathology
  • Benzamides
  • Dose-Response Relationship, Drug
  • Female
  • Glutamic Acid / genetics
  • Humans
  • Imatinib Mesylate
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / pathology
  • Lysine / genetics
  • Melanoma / drug therapy*
  • Melanoma / genetics
  • Melanoma / pathology
  • Neoplasm Metastasis
  • Piperazines / administration & dosage
  • Piperazines / therapeutic use*
  • Point Mutation* / physiology
  • Proto-Oncogene Proteins c-kit / genetics*
  • Pyrimidines / administration & dosage
  • Pyrimidines / therapeutic use*
  • Remission Induction

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Glutamic Acid
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit
  • Lysine